glp 1 tirzepatide peptide 10mg — GLP-1/GIP Dual-Agonist Research Semaglutide Vs Tirzepatide | GLP
Description
Effects of semaglutide on chronic kidney disease outcomes: a post hoc pooled analysis from the sustain 6 and pioneer 6 trials
July 7, 2016
In contrast, when analyzing stroke outcomes, the effect was more pronounced with GLP-1 RAs, which provided the greatest contribution to the reduction of stroke events
It could drive the neurology theranostic
Rev Neuroscience
A programme of phase 3 trials with retatrutide (TRIUMPH) is ongoing with an aim to assess the safety and efficacy of retatrutide in different populations living with obesity (OSA, T2D, established cardiovascular disease, osteoarthritis)
